Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q3 2024 | 164 | $442M | +$21M | -$28M | -$7.02M | IVE, COST, IVW, AAPL, AGG | 13F-HR | 12/19/2024, 02:12 PM |
Q2 2024 | 168 | $436M | +$25.8M | -$11.7M | +$14.1M | IVE, IVW, COST, AGG, AAPL | 13F-HR | 12/19/2024, 02:11 PM |
Q1 2024 | 171 | $421M | +$27.5M | -$18.7M | +$8.82M | IVE, IVW, COST, AGG, GVI | 13F-HR | 12/19/2024, 02:09 PM |
Q4 2023 | 166 | $390M | +$27.6M | -$36.5M | -$8.87M | IVE, IVW, COST, AGG, AAPL | 13F-HR | 12/19/2024, 01:30 PM |
Q3 2023 | 199 | $363M | +$35.8M | -$29M | +$6.74M | IVE, IVW, COST, AGG, GVI | 13F-HR | 12/19/2024, 01:29 PM |
Q2 2023 | 218 | $371M | +$26.1M | -$12.6M | +$13.5M | IVE, COST, IVW, AGG, AAPL | 13F-HR | 12/19/2024, 01:27 PM |
Q1 2023 | 210 | $339M | +$12.3M | -$18M | -$5.74M | IVE, COST, AGG, IVW, GVI | 13F-HR | 12/19/2024, 01:26 PM |
Q4 2022 | 213 | $328M | +$29.3M | -$25M | +$4.34M | IVE, AGG, COST, IVW, GVI | 13F-HR | 12/19/2024, 01:19 PM |
Q3 2022 | 208 | $305M | +$18.4M | -$14.5M | +$3.84M | IVE, COST, AGG, IVW, GVI | 13F-HR | 12/19/2024, 01:17 PM |
Q2 2022 | 216 | $321M | +$31M | -$41.4M | -$10.4M | IVE, COST, AGG, IVW, GVI | 13F-HR | 12/19/2024, 01:15 PM |
Q1 2022 | 212 | $392M | +$16.5M | -$14.8M | +$1.73M | IVE, IVW, COST, AGG, AAPL | 13F-HR | 12/19/2024, 01:13 PM |
Q4 2021 | 225 | $424M | +$17.8M | -$24.4M | -$6.59M | IVE, IVW, AGG, COST, AAPL | 13F-HR | 12/19/2024, 11:21 AM |
Q3 2021 | 211 | $403M | +$24M | -$22.1M | +$1.92M | IVE, IVW, AGG, COST, GVI | 13F-HR | 12/19/2024, 11:20 AM |
Q2 2021 | 201 | $412M | +$40.6M | -$12.9M | +$27.8M | IVE, IVW, AGG, GVI, ITOT | 13F-HR | 12/19/2024, 11:18 AM |
Q1 2021 | 188 | $364M | +$41.7M | -$8.38M | +$33.3M | IVE, IVW, AGG, GVI, ITOT | 13F-HR | 12/19/2024, 11:16 AM |
Q4 2020 | 178 | $320M | +$47.3M | -$9.62M | +$37.7M | IVE, IVW, AGG, ITOT, GVI | 13F-HR | 12/19/2024, 09:23 AM |
Q3 2020 | 159 | $262M | +$30.3M | -$13.7M | +$16.6M | IVE, IVW, AGG, ITOT, GVI | 13F-HR | 12/19/2024, 09:21 AM |
Q2 2020 | 151 | $234M | +$24.8M | -$6.57M | +$18.3M | IVE, IVW, AGG, ITOT, GVI | 13F-HR | 12/19/2024, 09:20 AM |
Q1 2020 | 127 | $181M | +$9.01M | -$17.9M | -$8.84M | IVE, IVW, AGG, ITOT, GVI | 13F-HR | 12/19/2024, 09:15 AM |
Q4 2019 | 155 | $226M | $0 | $0 | IVE, IVW, ITOT, AGG, IJH | 13F-HR | 12/13/2024, 12:06 PM |